Pharmaceutical Reviews Update — Issue 57

Details

Program Updates

1. Extension of Pilot for Societal Perspective in Pharmacoeconomic Evaluations

In March 2024, we initiated a pilot to incorporate the societal perspective into our pharmacoeconomic evaluations for certain new drugs that are submitted through our drug reimbursement review process. This pilot was set to conclude in July 2025.